LFR
VIVO

Lehman Financial Resources’s Meridian Bioscience Inc VIVO Stock Holding History

Lehman Financial Resources’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,000
Closed -$34K – 387
2015
Q3 		$34K Hold
2,000
– – 0.02% 190
2015
Q2 		$37K Hold
2,000
– – 0.02% 187
2015
Q1 		$38K Hold
2,000
– – 0.02% 185
2014
Q4 		$33K Hold
2,000
– – 0.02% 184
2014
Q3 		$35K Hold
2,000
– – 0.02% 182
2014
Q2 		$41K Buy
+2,000
New +$41.1K 0.02% 164

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Lehman Financial Resources's VIVO Position: Q4 2015 in Review

Lehman Financial Resources sold out of Meridian Bioscience Inc (VIVO) in Q4 2015, closing a stake of 2,000 shares — an estimated $34K sold.

Lehman Financial Resources first reported a position in VIVO in Q2 2014 and held it in 6 quarters. The position peaked at $41K in Q2 2014. 176 funds tracked by Wall St. Rank hold VIVO as of Q4 2015.

  • Lehman Financial Resources reported no remaining Meridian Bioscience Inc position as of Q4 2015 after selling out during the quarter.
  • Lehman Financial Resources sold 2,000 Meridian Bioscience Inc shares in Q4 2015, an estimated $34K.
  • Lehman Financial Resources first reported a position in Meridian Bioscience Inc in Q2 2014 and held it in 6 quarters.
  • Lehman Financial Resources's Meridian Bioscience Inc position peaked at $41K in Q2 2014.
  • 176 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2015.

Based on Lehman Financial Resources's 13F filing for Q4 2015, filed 17 Feb 2016.